• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-磷酸鞘氨醇通过细胞外作用诱导血小板活化,并与溶血磷脂酸共用一个血小板表面受体。

Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid.

作者信息

Yatomi Y, Yamamura S, Ruan F, Igarashi Y

机构信息

The Biomembrane Institute, Seattle, Washington 98119, USA.

出版信息

J Biol Chem. 1997 Feb 21;272(8):5291-7. doi: 10.1074/jbc.272.8.5291.

DOI:10.1074/jbc.272.8.5291
PMID:9030602
Abstract

Sphingosine 1-phosphate (Sph-1-P) has been implicated as an intracellular second messenger in many studies. We investigated the metabolism of Sph-1-P and the mechanism by which Sph-1-P induces activation in enucleated and highly differentiated platelets. Platelets lack Sph-1-P lyase activity, possess persistently active sphingosine (Sph) kinase, and abundantly store Sph-1-P. Although exogenous Sph-1-P activated platelets, intracellular Sph-1-P, formed from exogenously added Sph by cytosolic Sph kinase, failed to do so. To support the notion that exogenous Sph-1-P stimulates platelets from outside, contact of platelet surfaces with immobilized Sph-1-P covalently linked to glass particles resulted in platelet activation. Furthermore, we detected the specific binding sites for radiolabeled Sph-1-P on the platelet surface, suggesting extracellular effects of Sph-1-P on plasma membrane receptors. This specific Sph-1-P binding was inhibited not by other sphingolipids but by lysophosphatidic acid (LPA), and platelet aggregation response to LPA was specifically desensitized by prior addition of Sph-1-P. Finally, internally stored Sph-1-P is released extracellularly upon stimulation, and the release correlated well with protein kinase C activation in intact platelets. These results suggest that Sph-1-P acts not intracellularly but intercellularly, following discharge from activated platelets, and shares a platelet surface receptor with LPA.

摘要

在许多研究中,1-磷酸鞘氨醇(Sph-1-P)被认为是一种细胞内第二信使。我们研究了Sph-1-P的代谢以及Sph-1-P在去核且高度分化的血小板中诱导激活的机制。血小板缺乏Sph-1-P裂解酶活性,具有持续活跃的鞘氨醇(Sph)激酶,并大量储存Sph-1-P。尽管外源性Sph-1-P可激活血小板,但由胞质Sph激酶将外源性添加的Sph转化形成的细胞内Sph-1-P却无法激活血小板。为了支持外源性Sph-1-P从外部刺激血小板这一观点,血小板表面与共价连接到玻璃颗粒上的固定化Sph-1-P接触会导致血小板激活。此外,我们在血小板表面检测到了放射性标记的Sph-1-P的特异性结合位点,这表明Sph-1-P对质膜受体具有细胞外效应。这种特异性的Sph-1-P结合不受其他鞘脂的抑制,而是受溶血磷脂酸(LPA)的抑制,并且预先添加Sph-1-P可使血小板对LPA的聚集反应特异性脱敏。最后,内部储存的Sph-1-P在受到刺激时会释放到细胞外,并且这种释放与完整血小板中的蛋白激酶C激活密切相关。这些结果表明,Sph-1-P并非在细胞内起作用,而是在从活化血小板释放后在细胞间起作用,并且与LPA共享血小板表面受体。

相似文献

1
Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid.1-磷酸鞘氨醇通过细胞外作用诱导血小板活化,并与溶血磷脂酸共用一个血小板表面受体。
J Biol Chem. 1997 Feb 21;272(8):5291-7. doi: 10.1074/jbc.272.8.5291.
2
Sphingosine-1-phosphate as an intercellular signaling molecule.鞘氨醇-1-磷酸作为一种细胞间信号分子。
Ann N Y Acad Sci. 1998 Jun 19;845:19-31. doi: 10.1111/j.1749-6632.1998.tb09659.x.
3
Sphingosine 1-phosphate breakdown in platelets.血小板中鞘氨醇-1-磷酸的分解
J Biochem. 2004 Oct;136(4):495-502. doi: 10.1093/jb/mvh143.
4
Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells.鞘氨醇-1-磷酸是一种主要的生物活性溶血磷脂,由血小板释放并与内皮细胞相互作用。
Blood. 2000 Nov 15;96(10):3431-8.
5
Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration.血小板在血栓形成过程中释放的 1-磷酸鞘氨醇:血小板计数与血清 1-磷酸鞘氨醇浓度之间的密切相关性。
Lipids Health Dis. 2013 Feb 18;12:20. doi: 10.1186/1476-511X-12-20.
6
Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets.鞘氨醇-1-磷酸:一种从激动剂刺激的人血小板中释放的血小板激活鞘脂。
Blood. 1995 Jul 1;86(1):193-202.
7
Sphingosine 1-phosphate: synthesis and release.鞘氨醇-1-磷酸:合成与释放
Prostaglandins Other Lipid Mediat. 2001 Apr;64(1-4):107-22. doi: 10.1016/s0090-6980(01)00103-4.
8
Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate.
FEBS Lett. 2000 Feb 25;468(2-3):189-93. doi: 10.1016/s0014-5793(00)01222-9.
9
N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets.N,N-二甲基鞘氨醇对人血小板中鞘氨醇激酶和1-磷酸鞘氨醇活性的抑制作用
Biochemistry. 1996 Jan 16;35(2):626-33. doi: 10.1021/bi9515533.
10
Sphingosine 1-phosphate is a blood constituent released from activated platelets, possibly playing a variety of physiological and pathophysiological roles.1-磷酸鞘氨醇是一种从活化血小板释放的血液成分,可能发挥多种生理和病理生理作用。
Acta Biochim Pol. 1998;45(2):299-309.

引用本文的文献

1
IL-6 as a Mediator of Platelet Hyper-Responsiveness.白细胞介素-6作为血小板高反应性的介质
Cells. 2025 May 22;14(11):766. doi: 10.3390/cells14110766.
2
Platelet-Derived S1P and Its Relevance for the Communication with Immune Cells in Multiple Human Diseases.血小板衍生 S1P 及其在多种人类疾病中与免疫细胞通讯的相关性。
Int J Mol Sci. 2022 Sep 7;23(18):10278. doi: 10.3390/ijms231810278.
3
Sphingolipids in Hematopoiesis: Exploring Their Role in Lineage Commitment.鞘脂类在造血中的作用:探索其在谱系定向中的作用。
Cells. 2021 Sep 22;10(10):2507. doi: 10.3390/cells10102507.
4
Sphingosine-1-phosphate modulates PAR1-mediated human platelet activation in a concentration-dependent biphasic manner.鞘氨醇-1-磷酸以浓度依赖的双相方式调节 PAR1 介导的人血小板激活。
Sci Rep. 2021 Jul 28;11(1):15308. doi: 10.1038/s41598-021-94052-4.
5
Direct uptake of sphingosine-1-phosphate independent of phospholipid phosphatases.直接摄取鞘氨醇-1-磷酸,不依赖于磷脂磷酸酶。
J Biol Chem. 2021 Jan-Jun;296:100605. doi: 10.1016/j.jbc.2021.100605. Epub 2021 Mar 27.
6
Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.肿瘤相关血小板与脑胶质瘤血管生成:新型预后及靶向生物标志物的又一助力,使人们从关注局限性肿瘤转变为全身性病理改变。
Cells. 2020 Jan 25;9(2):294. doi: 10.3390/cells9020294.
7
Emerging Pharmacological Treatments for Cerebral Edema: Evidence from Clinical Studies.脑水肿的新兴药理学治疗方法:来自临床研究的证据。
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:291-309. doi: 10.1146/annurev-pharmtox-010919-023429.
8
Metabolic profiling of plasma from cardiac surgical patients concurrently administered with tranexamic acid: DI-SPME-LC-MS analysis.同时接受氨甲环酸治疗的心脏外科手术患者血浆的代谢谱分析:直接浸入式固相微萃取-液相色谱-质谱联用分析
J Pharm Anal. 2014 Feb;4(1):6-13. doi: 10.1016/j.jpha.2013.03.002. Epub 2013 Apr 11.
9
Translational Aspects of Sphingolipid Metabolism in Renal Disorders.肾脏疾病中神经鞘脂代谢的转译方面。
Int J Mol Sci. 2017 Nov 25;18(12):2528. doi: 10.3390/ijms18122528.
10
Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology.肝脏病理生物学中的鞘氨醇激酶与1-磷酸鞘氨醇
Crit Rev Biochem Mol Biol. 2017 Oct;52(5):543-553. doi: 10.1080/10409238.2017.1337706. Epub 2017 Jun 15.